Shailender Bhatia, Ted Gooley, Andrew Scott Brohl, Leslie Anne Fecher, Sunandana Chandra, Ling Gao, Ann W. Silk, Theresa Medina, Stergios J. Moschos, Wenwen Chen, Reina Hibbert, Sumia Dakhil, Samantha Kiriluk, Jenna M. Voutsinas, Paul Nghiem, Scott S. Tykodi, Ciara M. Kelly. "ADAM trial: A multicenter, randomized, double-blinded, placebo-controlled, phase 3 trial of adjuvant avelumab (anti-PD-L1 antibody) in patients with Merkel cell carcinoma and lymph node metastases.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.17_suppl.lba9504